Last edition
News about "Concord Biotech"
Concord Biotech Gujarat Plant Gets One US FDA Observation
Concord Biotech’s formulation facility in Gujarat has completed a US FDA inspection with one minor procedural observation, according to the company.
Concord Biotech | 19/09/2026 | By News Bureau | 108
Concord Biotech Successfully Completes ANVISA Inspection at Limbasi API Manufacturing Facility
Concord Biotech has successfully completed an ANVISA inspection at its Limbasi Active Pharmaceutical Ingredient (API) manufacturing facility, strengthening its regulatory standing and expansion into Brazil's pharmaceutical market.
Concord Biotech | 12/06/2026 | By News Bureau | 158
Concord Biotech | 23/08/2023 | By Sudeep Soparkar | 1505
Concord Biotech files DRHP for IPO
Concord Biotech is the leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology
Concord Biotech | 16/08/2022 | By Sudeep Soparkar | 1208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy